Equity Overview
Price & Market Data
Price: $0.075
Daily Change: $0.00 / 0.00%
Daily Range: $0.075 - $0.075
Market Cap: $21,550,804
Daily Volume: 11,000
Performance Metrics
1 Week: 10.46%
1 Month: 6.23%
3 Months: -4.70%
6 Months: 5.12%
1 Year: 116.1%
YTD: 9.17%
Company Details
Employees: 18
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. The company's lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein cholesterol, recent acute coronary syndrome, and post COVID-19 conditions. It has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.